Cinobufotalin injection combined with chemotherapy for the treatment of advanced NSCLC in China: A PRISMA-compliant meta-analysis of 29 randomized controlled trials

BACKGROUND AND OBJECTIVE: Cinobufotalin injection (CFI), a kind of Chinese medicine, has been considered as a promising complementary therapy option for advanced non-small cell lung cancer (NSCLC), but their efficacy and safety remain controversial. This study aimed to systematically evaluate the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fan, Yin, Yantong, Xu, Tiantian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736171/
https://www.ncbi.nlm.nih.gov/pubmed/31464940
http://dx.doi.org/10.1097/MD.0000000000016969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736171/
https://www.ncbi.nlm.nih.gov/pubmed/31464940
http://dx.doi.org/10.1097/MD.0000000000016969

Ejemplares similares